Concepedia

Cihan Yurdaydın

CY

Statistics

Publications

104

Citations

10.3K

H-Index

51

Active since

1989

Affiliations

Ankara University(Current)

Medizinische Hochschule Hannover

Koç University

Dicle University

Bursa Uludağ Üni̇versi̇tesi̇

Cihan Yurdaydın is an author at Ankara University specializing in viral hepatitis, liver disease, and antiviral therapy.

ORCID

Publications per year

1989–2024

104

Publications

104

Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

Patrick Marcellin, George Lau, Ferruccio Bonino et al. · New England Journal of Medicine · 2004 · 1.1K citations · Full text

, , +17

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

George Papatheodoridis, George Ν. Dalekos, Vana Sypsa et al. · Journal of Hepatology · 2015 · 541 citations

, , +13

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # †

Maurizia Rossana Brunetto, F. Moriconi, Ferruccio Bonino et al. · Hepatology · 2008 · 483 citations · Full text

, , +17

Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

Heiner Wedemeyer, Cihan Yurdaydın, George Ν. Dalekos et al. · New England Journal of Medicine · 2011 · 474 citations · Full text

, , +13

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

Morris Sherman, Cihan Yurdaydın, Jose D. Sollano et al. · Gastroenterology · 2006 · 414 citations · Full text

, , +11

1–5 of 104